DOR BIOPHARMA INC (DOR) is a publicly traded company in the Unknown sector. Across all available filings, 4 corporate insiders have executed 8 transactions totaling $150.0K, demonstrating a bullish sentiment with $150.0K in net insider flow. The most recent transaction on Feb 9, 2007 involved a purchase of 212,766 shares valued at $100.0K.
No significant insider buying has been recorded for DOR in the recent period.
No significant insider selling has been recorded for DOR in the recent period.
Based on recent SEC filings, insider sentiment for DOR is bullish with an Insider Alignment Score of 100/100 and a net flow of $150.0K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at DOR BIOPHARMA INC (DOR) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 4 insiders are actively trading DOR stock, having executed 8 transactions in the past 90 days. The most active insider is Steve H. Kanzer (Executive), who has made 2 transactions totaling $150.0K.
Get notified when executives and directors at DOR file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 9, 2007 | H. Kanzer Steve | Executive | Purchase | 212,766 | $0.47 | $100.0K | |
| Feb 9, 2007 | Myrianthopoulos Evan | Executive | Purchase | 53,191 | $0.47 | $25.0K | |
| Feb 9, 2007 | Clavijo James | Executive | Purchase | 53,191 | $0.47 | $25.0K | |
| Apr 10, 2006 | T. Sember Michael | Executive | Award | 180,440 | $0.45 | $81.2K | |
| Apr 10, 2006 | Myrianthopoulos Evan | Executive | Award | 90,220 | $0.28 | $25.3K | |
| Apr 10, 2006 | T. Sember Michael | Executive | Award | 180,440 | $0.28 | $50.5K | |
| Apr 10, 2006 | Myrianthopoulos Evan | Executive | Award | 90,220 | $0.28 | $25.3K | |
| Jan 20, 2006 | H. Kanzer Steve | Executive | Option Exercise | 250,000 | $0.20 | $50.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Award(A) | 4 | $182.2K | 47.7% |
Purchase(P) | 3 | $150.0K | 39.2% |
Exercise(M) | 1 | $50.0K | 13.1% |
Insiders at DOR BIOPHARMA INC are accumulating shares at an accelerated pace. With 4 insiders making 8 transactions totaling $150.0K in purchases versus $0 in sales, the net buying activity of $150.0K signals strong executive confidence. Steve H. Kanzer (Executive) leads the buying activity with $150.0K in transactions across all time.